iRay Technology Co Ltd - Asset Resilience Ratio
iRay Technology Co Ltd (688301) has an Asset Resilience Ratio of 0.68% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See iRay Technology Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how iRay Technology Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of iRay Technology Co Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down iRay Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of iRay Technology Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥67.04 Million | 0.68% |
| Total Liquid Assets | CN¥67.04 Million | 0.68% |
Asset Resilience Insights
- Limited Liquidity: iRay Technology Co Ltd maintains only 0.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
iRay Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare iRay Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tecan Group AG
SW:TECN |
Medical Instruments & Supplies | 20.48% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410 |
Medical Instruments & Supplies | 38.45% |
|
Formosa Optical Technology Co Ltd
TWO:5312 |
Medical Instruments & Supplies | 46.32% |
|
ZEN Graphene Solutions Ltd
V:ZEN |
Medical Instruments & Supplies | 4.79% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for iRay Technology Co Ltd (2020–2024)
The table below shows the annual Asset Resilience Ratio data for iRay Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.25% | CN¥113.28 Million ≈ $16.58 Million |
CN¥9.08 Billion ≈ $1.33 Billion |
-2.35pp |
| 2023-12-31 | 3.60% | CN¥270.44 Million ≈ $39.57 Million |
CN¥7.51 Billion ≈ $1.10 Billion |
-7.83pp |
| 2022-12-31 | 11.43% | CN¥665.29 Million ≈ $97.35 Million |
CN¥5.82 Billion ≈ $851.46 Million |
-12.19pp |
| 2021-12-31 | 23.62% | CN¥835.60 Million ≈ $122.27 Million |
CN¥3.54 Billion ≈ $517.59 Million |
-11.08pp |
| 2020-12-31 | 34.70% | CN¥1.00 Billion ≈ $147.03 Million |
CN¥2.90 Billion ≈ $423.68 Million |
-- |
About iRay Technology Co Ltd
iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-r… Read more